Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:BIOC

Biocept (BIOC) Stock Price, News & Analysis

Biocept logo

About Biocept Stock (NASDAQ:BIOC)

Advanced Chart

Key Stats

Today's Range
N/A
50-Day Range
$0.43
$1.67
52-Week Range
N/A
Volume
751,400 shs
Average Volume
764,067 shs
Market Capitalization
$1.14 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive BIOC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Biocept and its competitors with MarketBeat's FREE daily newsletter.

BIOC Stock News Headlines

This Signal Only Flashes Once Every 4 Years – And It Just Triggered
This same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in crypto. Now it’s back, and the smart money is already positioning. A free training reveals the step-by-step strategy and altcoin picks designed to help you capitalize on the next wave.
See More Headlines

BIOC Stock Analysis - Frequently Asked Questions

Biocept, Inc. (NASDAQ:BIOC) announced its earnings results on Monday, November, 15th. The medical research company reported $0.90 earnings per share for the quarter, missing the consensus estimate of $2.70 by $1.80. The medical research company had revenue of $17.47 million for the quarter, compared to analyst estimates of $16.87 million.

Biocept shares reverse split on Wednesday, May 17th 2023.The 1-30 reverse split was announced on Wednesday, May 17th 2023. The number of shares owned by shareholders was adjusted after the closing bell on Wednesday, May 17th 2023. An investor that had 100 shares of stock prior to the reverse split would have 3 shares after the split.

Based on aggregate information from My MarketBeat watchlists, some other companies that Biocept investors own include Advanced Micro Devices (AMD), Sorrento Therapeutics (SRNE), T2 Biosystems (TTOO), VBI Vaccines (VBIV), Vaxart (VXRT), NIO (NIO) and iBio (IBIO).

Company Calendar

Last Earnings
11/15/2021
Today
7/12/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Diagnostics & Research
Sub-Industry
N/A
Current Symbol
NASDAQ:BIOC
CIK
1044378
Employees
50
Year Founded
1993

Profitability

EPS (Trailing Twelve Months)
($58.4549)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$32.09 million
Net Margins
N/A
Pretax Margin
-564.02%
Return on Equity
-468.87%
Return on Assets
-118.41%

Debt

Debt-to-Equity Ratio
2.88
Current Ratio
1.81
Quick Ratio
1.70

Sales & Book Value

Annual Sales
$25.86 million
Price / Sales
0.00
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$15.60 per share
Price / Book
N/A

Miscellaneous

Outstanding Shares
2,630,000
Free Float
2,584,000
Market Cap
$1.14 million
Optionable
Not Optionable
Beta
0.69

Social Links

7 Energy Stocks to Buy and Hold Forever Cover

With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.

Get This Free Report

This page (NASDAQ:BIOC) was last updated on 7/12/2025 by MarketBeat.com Staff
From Our Partners